Fundraising FoxRevascularbio
Suita, JP · 1 known investors
Find your way into Revascularbio
Sign up to see every warm intro you have to Revascularbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Revascularbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders. The company targets intractable diseases with angiogenic therapy, angiocrine therapy, and protein production platforms.
Founders & leadership
SO
Shinsei OmoriRepresentative Director, President & CEO
Investors · 1
Frequently asked questions
- What does Revascularbio do?
- Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders. The company targets intractable diseases with angiogenic therapy, angiocrine therapy, and protein production platforms.
- Who are Revascularbio's investors?
- Revascularbio's investors include OSAKA University Venture Capital.
- Where is Revascularbio headquartered?
- Revascularbio is headquartered in Suita, JP.